Resources

Additional Resources

An educated patient has the best chance of success with therapy. He or she should ultimately decide for him or herself if they believe they can benefit from ketamine infusion therapy.

Current clinical trials:

Action of Ketamine in Treatment-Resistant Depression

Double Blind, Active, University of Ottawa

The Antidepressant Action of Ketamine: Brain Chemistry

Double Blind, Active, Columbia University

Continuation Ketamine in Major Depression

Double Blind, Completed, Icahn School of Medicine at Mount Sinai

Ketamine Infusion for Obsessive-Compulsive Disorder

Open Label, Completed, Yale University

Published studies

For Depression/Anxiety

For PTSD

For OCD